Literature DB >> 23018139

Previous exposure to cigarette smoke aggravates experimental cyclosporine-induced nephrotoxicity.

Sueli A Alves1, Carla P Carlos, Glória E F Mendes, Sandra M Oliveira, Marcus A M Luz, Rafael P S Souza, Rael L Matimoto, Terezila M Coimbra, Emmanuel A Burdmann.   

Abstract

BACKGROUND/AIMS: The effects of cigarette smoke (CS) on cyclosporine (CsA)-induced nephrotoxicity are poorly studied. This study aims to assess the effects of previous exposure to CS on CsA nephrotoxicity.
METHODS: Rats were either exposed to CS or sham (S) procedures for 10 min twice a day for 20 weeks. From the 16th to the 20th week, they received a low-salt diet. Beginning with the 17th week, they were given 2.5 mg/day CsA or vehicle (VH) for 3 weeks. The final groups were VH/CS, CsA/CS, VH/S, and CsA/S. On day 141, glomerular filtration rate (GFR), renal blood flow (RBF), renal vascular resistance (RVR), tubulointerstitial fibrosis, and CsA blood levels were measured and immunohistochemistry was analyzed for renal α-smooth muscle actin (SMA), nitrotyrosine, and vimentin.
RESULTS: CsA decrease in GFR was enhanced by CS exposure. CsA associated with CS induced higher periglomerular α-SMA and renal nitrotyrosine expression. CsA decreased RBF, but increased RVR, tubulointerstitial fibrosis, and α-SMA and renal vimentin expression. These changes and the CsA blood levels were not affected by CS exposure.
CONCLUSION: CS aggravated the CsA-induced impairment of GFR and CS associated with CsA caused the development of periglomerular structural lesions and oxidative stress in a rat model of CsA nephrotoxicity.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23018139     DOI: 10.1159/000342337

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  1 in total

1.  Smoking is a risk factor for the progression of idiopathic membranous nephropathy.

Authors:  Makoto Yamaguchi; Masahiko Ando; Ryohei Yamamoto; Shinichi Akiyama; Sawako Kato; Takayuki Katsuno; Tomoki Kosugi; Waichi Sato; Naotake Tsuboi; Yoshinari Yasuda; Masashi Mizuno; Yasuhiko Ito; Seiichi Matsuo; Shoichi Maruyama
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.